No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Leading Industry Expert Mike Treleaven VP of Tegra Medical to Serve on Rodman Media’s ODT Advisory Board

Editor: What To Know

  • Mike Treleaven will help to guide the magazine to ensure it stays atop critical topics, issues, and concerns that affect the orthopedic sector of the medical device industry.
  • Mike Treleaven has been part of the Tegra Medical family since 2001 when he joined Accumet Laser, one of the companies that merged to form Tegra Medical in 2007.
  • “Serving on the board for ODT is a great honor and I’m flattered to have been asked,”.

Mike Treleaven, VP of Tegra Medical to serve on the Rodman Media ODT advisory board. The news was announced today.

Mike Treleaven will help to guide the magazine to ensure it stays atop critical topics, issues, and concerns that affect the orthopedic sector of the medical device industry.

“The ODT editorial advisory board is an invaluable resource as it provides expertise on critical topics,” said Sean Fenske, ODT Editor-in-Chief. “We’ve previously tapped Mike for his expertise in interviews, articles, and videos. We’re looking forward to more of his insights into the key issues our industry faces. Rodman Media appreciates his ongoing dedication and commitment to becoming a board member.”

“Serving on the board for ODT is a great honor and I’m flattered to have been asked,” said Treleaven. “I have great respect for their contributions to the industry and hope my medical device and orthopedic experience can make a meaningful contribution.”

Mike Treleaven has been part of the Tegra Medical family since 2001 when he joined Accumet Laser, one of the companies that merged to form Tegra Medical in 2007. His focus has been on technology and new product development with the company’s GENESIS Tech Center® services. Mike attended the College of William & Mary and has a BS in Biology.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy